Half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit http://t.co/fBbLZuS804
— Dr. Avery Jenkins (@averyjenkinsdc) January 23, 2014
Half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit http://t.co/fBbLZuS804
— Dr. Avery Jenkins (@averyjenkinsdc) January 23, 2014